Histopathology of the primary tumours showed that fibroblastic FAK inactivation does not impact the general architecture and the proportion of tumour cells (CK19‐positive) vs fibroblasts (α‐SMA‐positive) (Fig 3B). The gene discussed is PTK2; the disease is neoplasm.